AR030715A1 - Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones - Google Patents
Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composicionesInfo
- Publication number
- AR030715A1 AR030715A1 ARP010104207A ARP010104207A AR030715A1 AR 030715 A1 AR030715 A1 AR 030715A1 AR P010104207 A ARP010104207 A AR P010104207A AR P010104207 A ARP010104207 A AR P010104207A AR 030715 A1 AR030715 A1 AR 030715A1
- Authority
- AR
- Argentina
- Prior art keywords
- flavored
- mixtures
- pharmaceutical compositions
- flavoring
- flavoring systems
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
Abstract
Sistemas saborizantes para una composicion farmacéutica líquida y composiciones farmacéuticas que contienen dichos sistemas saborizantes. Los sistemas saborizantes de la invencion incluyen por lo menos un agente edulcorante, por lo menos dos ingredientes con sabor, y por lo menos un modificador del sabor que se selecciona entre el grupo que consiste en ácido cítrico, citrato de sodio, cloruro de sodio y mezclas de los mismos. Por lo menos dos de los ingredientes saborizados se seleccionan entre el grupo que consiste en un ingrediente con sabor a vainilla, un ingrediente con sabor a menta, un ingrediente con sabor a mentol, un ingrediente con sabor a algodon de azucar, y mezclas de los mismos. El (los) agente(s) edulcorante(s) comprende(n) glicerina, glicirricinato de monoamonio, sacarina sodica, acesulfame potásico, jarabe de maíz de alta fructosa, y/o mezclas de los mismos. Las composiciones farmacéuticas de la invencion incluyen un sistema saborizante de la invencion, un sistema solvente, y por lo menos un agente farmacéuticamente activo, como por ejemplo lopinavir o derivados del mismo, ritonavir o derivados del mismo, o mezclas de los mismos. También se describen métodos para hacer dichas composiciones farmacéuticas líquidas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65519200A | 2000-09-05 | 2000-09-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR030715A1 true AR030715A1 (es) | 2003-09-03 |
Family
ID=24627898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010104207A AR030715A1 (es) | 2000-09-05 | 2001-09-04 | Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1315487A2 (es) |
| JP (1) | JP2004522698A (es) |
| AR (1) | AR030715A1 (es) |
| AU (1) | AU2001288695A1 (es) |
| BR (1) | BR0108433A (es) |
| CA (1) | CA2417258A1 (es) |
| MX (1) | MXPA03001952A (es) |
| PE (1) | PE20020373A1 (es) |
| UY (1) | UY26925A1 (es) |
| WO (1) | WO2002020057A2 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE329579T1 (de) | 1999-11-12 | 2006-07-15 | Abbott Lab | Feste dispersion mit ritonavir, fenofibrat oder griseofulvin |
| AU2003295589A1 (en) * | 2002-11-22 | 2004-06-18 | Noville, Inc. | Oral compositions which mask the salty taste of salts |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| GB2423711B (en) * | 2005-10-24 | 2007-02-14 | Fortune Apex Dev Ltd | Method for preparing a pharmaceutical composition with enhanced mucoadhesion |
| JPWO2013129436A1 (ja) * | 2012-02-29 | 2015-07-30 | 武田薬品工業株式会社 | 経口剤 |
| US8771651B2 (en) * | 2012-09-10 | 2014-07-08 | Johnson & Johnson Consumer Companies, Inc. | Mouth rinses and tooth sensitivity treatment compositions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111991A (en) * | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
| AU3146997A (en) * | 1996-06-03 | 1998-01-05 | Merck & Co., Inc. | Pediatric formulation for hiv protease inhibitors |
-
2001
- 2001-09-04 UY UY26925A patent/UY26925A1/es not_active Application Discontinuation
- 2001-09-04 JP JP2002524540A patent/JP2004522698A/ja not_active Withdrawn
- 2001-09-04 CA CA002417258A patent/CA2417258A1/en not_active Abandoned
- 2001-09-04 EP EP01968449A patent/EP1315487A2/en not_active Withdrawn
- 2001-09-04 BR BRPI0108433-0A patent/BR0108433A/pt not_active IP Right Cessation
- 2001-09-04 PE PE2001000889A patent/PE20020373A1/es not_active Application Discontinuation
- 2001-09-04 AU AU2001288695A patent/AU2001288695A1/en not_active Abandoned
- 2001-09-04 MX MXPA03001952A patent/MXPA03001952A/es unknown
- 2001-09-04 WO PCT/US2001/027415 patent/WO2002020057A2/en not_active Application Discontinuation
- 2001-09-04 AR ARP010104207A patent/AR030715A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004522698A (ja) | 2004-07-29 |
| UY26925A1 (es) | 2002-04-26 |
| AU2001288695A1 (en) | 2002-03-22 |
| BR0108433A (pt) | 2006-06-06 |
| EP1315487A2 (en) | 2003-06-04 |
| MXPA03001952A (es) | 2003-09-10 |
| WO2002020057A2 (en) | 2002-03-14 |
| PE20020373A1 (es) | 2002-05-13 |
| CA2417258A1 (en) | 2002-03-14 |
| WO2002020057A3 (en) | 2002-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1114631T1 (el) | Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο | |
| BR0010984A (pt) | Matrizes porosas de medicamento e processos para fabricação das mesmas | |
| AR073793A1 (es) | Formulacion farmaceutica liquida que contiene paracetamol. excipiente liquido | |
| TR200002812T2 (tr) | Efervesan formülasyonları. | |
| ITMI20021392A1 (it) | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' | |
| PA8509001A1 (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| WO2005020962A8 (en) | Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs | |
| CO5560580A2 (es) | Formulaciones de sucralosa para disumular sabores desagradables | |
| NO20052408D0 (no) | Farmasoytisk formulering av olanzapin | |
| DK342989A (da) | Betaendelseshaemmende middel | |
| AR030715A1 (es) | Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones | |
| PE20030545A1 (es) | Formulaciones de jarabe de ribavirina | |
| AR023138A1 (es) | Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso | |
| ES2312921T3 (es) | Disolucion acuosa concentrada de ambroxol. | |
| AR006345A1 (es) | Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion. | |
| WO2004069187A3 (en) | Drug formulation and delivery using crystalline methylated cyclodextrins | |
| ES2310550T3 (es) | Preparacion liquida acuosa de pranoprofeno. | |
| ATE242626T1 (de) | Wasserlösliche pharmazeutische darreichungsform, ausgenommen brause-formen, welche nicht- steroidale antientzündliche wirkstoffe enthält | |
| BR0302523A (pt) | Composição farmacêutica estável para administração de inibidores da hiv protease e processo de obtenção de composição farmacêutica concentrada para a administração de inibidores da hiv protease | |
| CO4970788A1 (es) | Formulaciones orales para drogas hidrofilicas | |
| JP2007008852A (ja) | プラバスタチンを含有する水性製剤の安定化方法 | |
| TH51212A (th) | ระบบแต่งรสชาติสำหรับองค์ประกอบทางเภสัชกรรมและวิธีการเตรียมองค์ประกอบดังกล่าว | |
| CA2954392A1 (en) | Diclofenac sublingual spray | |
| BR0202252A (pt) | Composição farmacêutica solúvel estável para administração de inibidores da hiv protease e processo de obtenção de composições farmacêuticas concentradas para a administração de inibidores da hiv protease | |
| JP2003055247A (ja) | 内服用液剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |